DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cycloguanil
Cycloguanil
Plasmodium Falciparum Clinical Isolates: in Vitro Genotypic and Phenotypic Characterization Nonlawat Boonyalai1* , Brian A
Treatment Failure Due to the Potential Under-Dosing of Dihydroartemisinin-Piperaquine in a Patient with Plasmodium Falciparum Uncomplicated Malaria
The Use of Long Acting Sulfonamides. Alone Or with Pyrimethamine, in Malaria (With Special Reference to Sulformetoxine)
Malarial Dihydrofolate Reductase As a Paradigm for Drug Development Against a Resistance-Compromised Target
Evidence of Pyrimethamine and Cycloguanil Analogues As Dual Inhibitors of Trypanosoma Brucei Pteridine Reductase and Dihydrofolate Reductase
Pyrimethamine and Proguanil Are the Two Most Widely Used DHFR Inhibitor Antimalarial Drugs. Cycloguanil Is the Active Metabolite of the Proguanil (1,2)
Current Antimalarial Therapies and Advances in the Development of Semi-Synthetic Artemisinin Derivatives
Pyronaridine-Artesunate for Treating Uncomplicated Plasmodium Falciparum Malaria (Review)
Investigating the Potential of Primary Sulfonamides As Antimalarial
Final1-Aritmo-Final-Report-V2-0Final.Pdf
Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
Index Vol. 16-23
Plasmodium Falciparum Phenotypic and Genotypic Resistance Profile
Quinine) and to Prevent Malaria (Mefloquine, Cycloguanil) in Comoros Union and Madagascar
Development of Analytical Methods for the Determination of Antimalarials
Therapeutic Technologies: Selected Tropical Diseases Contents
The Genetics of Resistance to Antifolate and Sulfa Drugs in Malaria Parasites
( 12 ) United States Patent
Top View
MALARONE® (Atovaquone and Proguanil Hydrochloride) Tablets MALARONE® (Atovaquone and Proguanil Hydrochloride) Pediatric Tablets
Australian Statistics on Medicines 2009
Quantitative Assessment of Plasmodium Falciparum PNAS PLUS Sexual Development Reveals Potent Transmission- Blocking Activity by Methylene Blue
Wo 2007/044693 A2
Molecular Surveillance and in Vitro Drug Sensitivity Study of Plasmodium Falciparum Isolates from the China–Myanmar Border
Cyclization-Blocked Proguanil As a Strategy to Improve the Antimalarial Activity of Atovaquone
In Silico Drug Discovery on Computational Grids for Finding Novel Drugs Against Neglected Diseases
Proguanil and Cycloguanil Are Organic Cation Transporter and Multidrug and Toxin Extrusion Substrates Maarten Van Der Velden1, Albert Bilos1, Jeroen J
Methods and Techniques for Assessing Exposure to Antimalarial Drugs in Clinical fi Eld Studies
Guidelines for the Treatment of Malaria
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
Antimalarial Efficacy and Drug Interactions of the Novel Semi
Early Treatment Failure During Treatment of Plasmodium Falciparum
Synergism Between Antineoplastics and Antimalarials on Breast Cancer Cells
Minutes of 5Th TEG on Drug Efficacy and Response Meeting
Failure of Dihydroartemisinin-Piperaquine (DHA-PPQ) for the Treatment of P
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
A Population Pharmacokinetic Model of Piperaquine in Pregnant and Non
Masked Quinine Formulations for Flexible Pediatric Drug Dosing in Oral Treatment of Malaria
MALARONE Tablets Are Round, Biconvex, Pink Film Coated Tablets, Engraved on One Side with “GX CM3”
Confidential Clinical Trial Protocol
Molecular Basis of Differential Resistance to Cycloguanil and Pyrimethamine in Plasmodium Falciparum Malaria DAVID S
ATC Code Title
CHAPTER E26 Pharmacology of Agents Used to Treat Parasitic Infections
Microbiology Review(S)